Reprogramming the immune system: A new era of precision immunotherapy for cancer and autoimmune disease with Travis Young, PhD
Your immune system is your body’s natural defense, capable of identifying what belongs and what doesn’t. But when it falters, it can let cancer grow unchecked or mistakenly attack your own healthy tissues, leading to autoimmune diseases. What if we could reprogram the immune system to tip the balance in our favor, gaining an advantage over both cancers and autoimmune disorders? In this free Front Row lecture, Calibr-Skaggs’ vice president of biologics, Travis Young, will share how Scripps Research is using genetic engineering to reprogram patients’ own immune cells to create personalized “switchable” CAR-T cell therapies. This approach represents a new class of precision immunotherapy designed to induce deep and durable remissions in patients with a wide range of cancers, from lymphoma to breast cancer, as well as in chronic autoimmune conditions such as lupus, rheumatoid arthritis and systemic sclerosis. Young will explain how this breakthrough strategy works and what it could mean for the future of medicine.
Learn more at frontrow.scripps.edu.
About Scripps Research
Committed to unraveling the intricacies of the human body and translating our discoveries into tangible global impact, Scripps Research is consistently ranked among the most influential non-profit research institutes in the world. Throughout our 100-year history, our scientists have expanded the boundaries of scientific understanding and played a pivotal role in the development of 17 FDA-approved medicines that have impacted the lives of countless individuals worldwide.
The Front Row lecture series, now in its eighth season, offers an exclusive glimpse into groundbreaking scientific discoveries in action. Many of these breakthroughs are the result of years of tireless work—made possible by the support of our community.
As we enter another century of science changing life at Scripps Research, our focus remains the same: fueling world-class fundamental and translational research to accelerate the development of medical advances for the benefit of human health.
